LAKE FOREST, Ill.–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it, in partnership with Illinois Governor JB Pritzker, has provided $500,000 to the Illinois COVID-19 Response Fund and $500,000 to the Illinois Biotechnol… […]
The European Medicines Agency (EMA) on Wednesday released for consultation a new draft guideline on points that clinical trial sponsors should consider on the implications of the coronavirus disease (Covid-19) on methodological aspects of ongoing trial… […]
LOS ANGELES–(BUSINESS WIRE)–XPRIZE, the world?s leader in designing and operating incentive competitions to solve humanity?s grand challenges, reveals the XPRIZE Pandemic Alliance, a global coalition that combines the power of collaboration, competit… […]
MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced it has entered into a technology l… […]
HUNTINGTON BEACH, Calif.–(BUSINESS WIRE)– #lsintelligence–Life Science Intelligence (LSI) and Health Research International (HRI) have been tracking and publishing market data on the global medical devices & diagnostics market for over three dec… […]
TORRANCE, Calif., March 24, 2020 (GLOBE NEWSWIRE) — Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease (SCD) treatment, announced today several steps it has taken in response to the Coronavirus (COVID-19) pandemic. Within the … […]
PASADENA, Calif., March 24, 2020 (GLOBE NEWSWIRE) — OmniPathology today announced the launch of its COVID-19 Lab Developed Test LDT. In response to the US Food and Drug Administration (FDA) policy announcement on February 29, 2020, seeking high comp… […]
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–CureDuchenne, the leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, is rolling out a comprehensive suite of online resources for the Duchenne community. This suite of… […]
In the latest upswing on the CytomX roller coaster ride, Astellas is stoking the waning flames of its platform tech with $80 million upfront and a new partnership.
Specifically, the Japanese pharma is interested in applying the Probody tech on T cell e… […]
WESTLAKE VILLAGE, Calif., March 23, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological d… […]
Copyright © 2026 Biotech Networks, LLC
